1. Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms
- Author
-
Lalao Randimbison, Fabio Levi, C. La Vecchia, and V.-C. Te
- Subjects
Adult ,Cancer Research ,medicine.medical_specialty ,Second Neoplasms ,Adolescent ,ovarian tumours ,serous tumours ,Ovary ,Cystadenocarcinoma, Mucinous ,survival ,mucinous tumours ,Epidemiology ,medicine ,Humans ,cancer registration ,Ovarian tumours ,Aged ,Gynecology ,Ovarian Neoplasms ,time trends ,Relative survival ,borderline tumours ,business.industry ,Incidence (epidemiology) ,Cystadenocarcinoma, Mucinous/complications ,Cystadenocarcinoma, Mucinous/epidemiology ,Cystadenocarcinoma, Serous/complications ,Cystadenocarcinoma, Serous/epidemiology ,Female ,Incidence ,Middle Aged ,Neoplasms, Second Primary/complications ,Neoplasms, Second Primary/epidemiology ,Ovarian Neoplasms/complications ,Ovarian Neoplasms/epidemiology ,Survival Analysis ,Switzerland/epidemiology ,Neoplasms, Second Primary ,Regular Article ,low malignant potential tumours ,Cancer registry ,Cystadenocarcinoma, Serous ,Serous fluid ,second primary ,medicine.anatomical_structure ,Oncology ,business ,Switzerland - Abstract
Between 1976 and 1996, 176 borderline ovarian tumours were registered in the Cancer Registry of the Swiss canton of Vaud, corresponding to an age-adjusted incidence (world standard) of 2.7 in 100 000. Incidence rose from 1.7 per 100 000 during 1976–81 to 2.7 per 100 000 during 1987–91, and then levelled off; 58% of cases were serous and 41% mucinous. Relative survival was 94% at 10 years; 18 second neoplasms were observed, compared with 10.3 expected, and there was a significant excess of invasive ovarian cancers (four observed, including three synchronous, compared with 0.4 expected). © 1999 Cancer Research Campaign
- Published
- 1999